IL13 and asthma: Therefore, in this review, the IL-4/IL-13 signaling pathways and therapeutic monoclonal antibodies targeting each cytokine or their receptors, as well as dual IL-4/IL-13 blockade, in both AR and asthma are presented and discussed.